logo

 

The Omega-3 Research Institute, Inc. (O3RI) is an independent, not-for-profit corporation devoted to facilitation of research, communication and education on omega-3 (n-3) polyunsaturated fatty acids (PUFAs). O3RI pursues the elucidation and understanding of the functions and mechanisms by which omega-3 PUFAs exert their physiologic effects in nutrition, prevention of disease and therapeutics. It also seeks to reach a better understanding of the roles omega-3 PUFAs play as essential fatty acids (EFAs) among saturated, monounsaturated (MUFA) and other PUFAs, such as the omega-6s (n-6). O3RI strives to facilitate communication among scientists in the appropriate fields, to foster research and development and to educate professionals, the public and officials of the roles of omega-3 PUFA in health and disease.

Omega-3 Research Institute, Inc.
16700 Sioux Lane, Gaithersburg, MD 20878-2045
Tel: 301/977-3086, E-Mail: omega3ri@aol.com
Website URL:  http://www.omega3ri.org
 

Website under revision!  We shall be back soon!!

(click on the blue hyperlinks below for further information)

 

button

Research

  n Consortium for Brain Fatty Acids (CFBFA):  Providing Analytical, Research and Development Services for the International Neuroscience Community

 

button

Communication

n

Omega-3 Fatty Acids, Diabetes and Cardiovascular Risk:  An International Workshop
Post Workshop Summary
November 30-December 2, 2000, Holiday Inn Bethesda, Bethesda, Maryland)

n

International Workshop on Omega-3 Fatty Acids and Primary Prevention of Coronary Heart Disease, May, 2002 Delta Center-Ville Hotel, Montreal, Canada; (A Satellite Meeting of the 5th ISSFAL Congress, May 7-11, 2002,)
n Assessing Coronary Heart Disease (CHD) Risks With PUFA Biomarkers: An International Workshop. Sunday, 27 June 2004, The Brighton Centre, Brighton, UK (A Satellite Workshop of the ISSFAL Congress 2004, June 27-July 1, 2004)

n

International Workshop on "Brain Uptake and Utilization of Fatty Acids:  Application to Peroxisomal Biogenesis Disorders": Agenda, Session Summaries and Recommendations.

n

Comments on U.S. FDA Docket # 94N-0103 on the statement:  "Omega-3 fatty acids lower the risk of coronary heart disease"
o Bulletin board for scientific interchange

button

Education

o

Seminars on "Recommended Daily Intakes of n-3 and n-6 fatty acids"
-For physicians

-For nutritionists
-For teachers

o

Seminar for the public on:
-"Fats and lipids: How to balance fat intake wisely"

-"What available foods contain omega-3 and omega-6 fats?"

 

button

About Omega-3 Research Institute, Inc.

n

 Mission statement

n

 Board of Directors

n

 Scientific and Program Advisory Boards

  Return to Top of Page